TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study.

OBJECTIVES The TGF-β/Smad signaling pathway regulates diverse cellular functions, including tooth development, and is involved in numerous pathological processes such as tumorigenesis. The aim of this study was to investigate the immunoexpression of the TGF-β/Smad signaling pathway members in ameloblastoma (AM), calcifying cystic odontogenic tumor (CCOT), and adenomatoid odontogenic tumor (AOT). MATERIALS AND METHODS This retrospective cross-sectional study included 65 tissue specimens: 34 AMs, 13 CCOTs, and 18 AOTs. Serial sections were immunohistochemically stained with TGF-β1, Smad-4, Smad-1/-5/-8, and Smad-2/-3 antibodies, and a semiquantitative measurement of the positive cells was carried out by two oral pathologists using a 0-3 scale (0: no immunoreactivity, 1: <20% positive cells, 2: 20-50% positive cells, 3: >50% positive cells). RESULTS All biomarkers studied were found significantly decreased in AM compared to CCOT and AOT. AOT and CCOT expressed Smad-1/-5/-8 more strongly compared to AM (OR = 11.66, P < 0.001 and OR = 5.34, P = 0.013, respectively), and Smad-2/-3 immunostaining was found significantly increased in CCOT (OR = 10.42, P = 0.001) and AOT (OR = 5.16, P < 0.004) compared to AM. Similarly, Smad-4 was expressed more strongly in AOT and CCOT compared to AM (P = 0.001), while AOT demonstrated a fivefold higher chance to express TGF-β1 compared to AM (P = 0.011). CONCLUSION TGF-β/Smad signaling pathway is activated in AM, AOT, and CCOT. The statistically significant reduced TGF-β1/Smad immunoexpression in AM compared to AOT/CCOT could be associated with the more aggressive biological behavior of AM including increased cell proliferation and reduced apoptosis and differentiation. Thus, the biomarkers TGF-β, Smad-4, Smad-1/-5/-8, and Smad-2/-3 could serve as supplementary diagnostic indices between odontogenic tumors of high and low neoplastic dynamics.

[1]  S. Baredes,et al.  Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma , 2013, Head & neck.

[2]  Song Liu,et al.  Expression and clinical significance of the transforming growth factor‐β signalling pathway in endometrial cancer , 2011, Histopathology.

[3]  C. Heldin,et al.  Role of Smads in TGFβ signaling , 2011, Cell and Tissue Research.

[4]  Yixiang Wang,et al.  TGF-β1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma , 2011, Journal of dental research.

[5]  R. Medeiros,et al.  Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk , 2011, Journal of Cancer Research and Clinical Oncology.

[6]  Hongmei Zhou,et al.  Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts , 2011, BMC Cancer.

[7]  P. Coates,et al.  Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[8]  A. Botezatu,et al.  TGF-beta signalling pathway factors in HPV-induced cervical lesions. , 2010, Roumanian archives of microbiology and immunology.

[9]  Y. Chai,et al.  Smad4-Shh-Nfic Signaling Cascade–Mediated Epithelial-Mesenchymal Interaction Is Crucial in Regulating Tooth Root Development , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  X. Yang,et al.  Disruption of Smad4 in Odontoblasts Causes Multiple Keratocystic Odontogenic Tumors and Tooth Malformation in Mice , 2009, Molecular and Cellular Biology.

[11]  J. Bai,et al.  Growth inhibition induced by transforming growth factor-β1 in human oral squamous cell carcinoma , 2009, Molecular Biology Reports.

[12]  F. Carinci,et al.  Expression of Transforming Growth Factor &bgr;1 in Ameloblastomas , 2008, The Journal of craniofacial surgery.

[13]  K. Miyazono,et al.  Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway , 2008, Oncogene.

[14]  K. Tian,et al.  MMPs, TIMP‐2, and TGF‐β1 in the cancerization of oral lichen planus , 2008, Head & neck.

[15]  N. Nikitakis,et al.  Expression and alterations of the PTEN / AKT / mTOR pathway in ameloblastomas. , 2008, Oral diseases.

[16]  N. Deane,et al.  Smad7 induces hepatic metastasis in colorectal cancer , 2008, British Journal of Cancer.

[17]  C. Sturgis,et al.  Transforming Growth Factor-β1, Transforming Growth Factor-β2, and Transforming Growth Factor-β3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition , 2008, Molecular Cancer Research.

[18]  J. Freeman,et al.  Smad4-dependent TGF-β Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells* , 2008, Journal of Biological Chemistry.

[19]  W. Oh,et al.  Influence of TGF-β1 on the expression of BSP, DSP, TGF-β1 receptor I and Smad proteins during reparative dentinogenesis , 2008, Journal of Molecular Histology.

[20]  M. Marcantonio,et al.  Loss of expression of TGF-β1, TβRI, and TβRII correlates with differentiation in human oral squamous cell carcinomas , 2008 .

[21]  H. Munshi,et al.  Transforming Growth Factor-β1 Promotes Matrix Metalloproteinase-9–Mediated Oral Cancer Invasion through Snail Expression , 2008, Molecular Cancer Research.

[22]  H. Kumamoto,et al.  Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[23]  S. Park,et al.  Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation. , 2007, Cancer letters.

[24]  G. Su,et al.  Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. , 2007, Cancer letters.

[25]  D. Wong,et al.  Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. , 2006, Neoplasia.

[26]  E. K. Parkinson,et al.  Dysregulated TGF-β1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-β signalling pathway in human head and neck carcinoma cell lines , 2006 .

[27]  Z. Bian,et al.  Epithelial expression of SHH signaling pathway in odontogenic tumors. , 2006, Oral oncology.

[28]  H. Kumamoto,et al.  Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. , 2006, Oral diseases.

[29]  H. Kumamoto.  Molecular pathology of odontogenic tumors. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[30]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[31]  C. Hill,et al.  Smad4 Dependency Defines Two Classes of Transforming Growth Factor β (TGF-β) Target Genes and Distinguishes TGF-β-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses , 2005, Molecular and Cellular Biology.

[32]  S. Prime,et al.  The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II). , 2004, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[33]  S. Prime,et al.  TGF-β Signal Transduction in Oro-facial Health and Non-malignant Disease (Part I) , 2004 .

[34]  H. Kumamoto,et al.  K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[35]  H. Kumamoto,et al.  Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  H. Kumamoto,et al.  Immunohistochemical Analysis of Benign Mixed and Mesenchymal Odontogenic Tumors , 2003 .

[37]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[38]  I. Shih,et al.  Calcifying odontogenic cyst: clinicopathological features and immunohistochemical profile of 10 cases. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[39]  C. Hill,et al.  Stoichiometry of Active Smad-Transcription Factor Complexes on DNA* , 2002, The Journal of Biological Chemistry.

[40]  M. Matzuk,et al.  Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .

[41]  H. Kumamoto,et al.  Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[42]  S. Knuutila,et al.  Gene Expression Profiling of Ameloblastoma and Human Tooth Germ by Means of a cDNA Microarray , 2002, Journal of dental research.

[43]  S. Knuutila,et al.  Cell proliferation and chromosomal changes in human ameloblastoma. , 2002, Cancer genetics and cytogenetics.

[44]  S. Natsugoe,et al.  Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[46]  J. Farges,et al.  TGFβ1 Signaling and Stimulation of Osteoadherin in Human Odontoblasts In Vitro , 2002 .

[47]  N. Nakamura,et al.  Two relatively distinct patterns of ameloblastoma: an anti‐apoptotic proliferating site in the outer layer (periphery) and a pro‐apoptotic differentiating site in the inner layer (centre) , 2001, Histopathology.

[48]  H. Kumamoto,et al.  Detection of cell cycle-related factors in ameloblastomas. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[49]  S. Natsugoe,et al.  Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  J. Massagué,et al.  How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.

[51]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[52]  K. Yanagisawa,et al.  Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers , 2000, Oncogene.

[53]  Lin Chen,et al.  Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice , 2000, Oncogene.

[54]  R. Hruban,et al.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. , 2000, Cancer research.

[55]  S. Sato,et al.  Immunoexpression of transforming growth factor β in desmoplastic ameloblastoma , 2000, Virchows Archiv.

[56]  K. Miyazono,et al.  Intracellular Signaling of the TGF‐β Superfamily by Smad Proteins , 1999 .

[57]  N. Park,et al.  Terminal Differentiation of Normal Human Oral Keratinocytes Is Associated with Enhanced Cellular TGF-β and Phospholipase C-γ1 Levels and Apoptotic Cell Death , 1999 .

[58]  Takeo Iwama,et al.  Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.

[59]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[60]  J. Graff,et al.  Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.

[61]  A. Symons,et al.  Expression of Transforming Growth Factor-beta 1 (TGF-β1) in the Developing Periodontium of Rats , 1998, Journal of dental research.

[62]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[63]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[64]  A. Yamaguchi,et al.  Immunohistochemical demonstration of bone morphogenetic protein in odontogenic tumors. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[65]  H. Lodish,et al.  Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia , 1997 .

[66]  C. Heldin,et al.  Identification of Smad2, a Human Mad-related Protein in the Transforming Growth Factor β Signaling Pathway* , 1997, The Journal of Biological Chemistry.

[67]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[68]  B. Hogan.  Bone morphogenetic proteins in development. , 1996, Current opinion in genetics & development.

[69]  R. W. Padgett,et al.  Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[71]  R. Happonen,et al.  Transforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors. , 1993, The Journal of clinical investigation.

[72]  A. Vaahtokari,et al.  Associations between transforming growth factor beta 1 RNA expression and epithelial-mesenchymal interactions during tooth morphogenesis. , 1991, Development.

[73]  P. Donahoe,et al.  Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells , 1986, Cell.

[74]  R. Derynck,et al.  Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7 , 1986, Somatic cell and molecular genetics.

[75]  R. Happonen,et al.  Observations by G-banding in benign odontogenic tumors. , 1986, Cancer genetics and cytogenetics.

[76]  R. Brentani,et al.  Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[77]  J. Massagué.  How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.

[78]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[79]  M. Reiss.  Transforming growth factor-beta and cancer: a love-hate relationship? , 1997, Oncology research.

[80]  W. Gelbart,et al.  Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. , 1995, Genetics.

[81]  R. D'Souza,et al.  Analysis of Tooth Development in Mice Bearing a TGF-β1 Null Mutation , 1995 .

[82]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[83]  R. Derynck,et al.  Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family. , 1988, Oncogene research.